Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 2/20 | 0.55 |
| ▸ | RECQL | P46063 | 1/20 | 0.55 |
| ▸ | MAOA | P21397 | 2/20 | 0.53 |
| ▸ | MAOB | P27338 | 2/20 | 0.53 |
| ▸ | KDM1A | O60341 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 3/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.52 |
| ▸ | RAB9A | P51151 | 3/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | NPC1 | O15118 | 2/20 | 0.52 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.47 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 2/20 | 0.46 |
| ▸ | GFER | P55789 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8778016 | 1.00 | HPGD (0.55) | HPGDRECQLMAOAMAOBKDM1A | |
| SCHEMBL14862724 | 0.98 | MAOA (0.54) | HPGDRECQLMAOAMAOBKDM1A | |
| Methyl Alcohol SCHEMBL28270513 | 0.97 | HPGD (0.56) | HPGDRECQLMAOAMAOBKDM1A | |
| Hydrochloric Acid SCHEMBL16464069 | 0.97 | MAOA (0.53) | HPGDRECQLMAOAMAOBKDM1A | |
| SCHEMBL31706160 | 0.95 | MAOA (0.54) | HPGDRECQLMAOAMAOBKDM1A | |
| SCHEMBL662711 | 0.91 | MAOA (0.57) | HPGDRECQLMAOAMAOBKDM1A | |
| Hydrochloric Acid SCHEMBL4799055 | 0.89 | MAOA (0.55) | HPGDRECQLMAOAMAOBKDM1A | |
| SCHEMBL13280435 | 0.88 | MAOA (0.55) | HPGDRECQLMAOAMAOBKDM1A | |
| SCHEMBL13276199 | 0.84 | MAOA (0.62) | HPGDRECQLMAOAMAOBKDM1A | |
| SCHEMBL15456460 | 0.84 | MAOA (0.62) | HPGDRECQLMAOAMAOBKDM1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109293686-B | Containing CuⅡSecondary coordination compound, preparation method thereof and application thereof as urease inhibitor | 辽宁大学 | 2020-08-25 | — | — | CN | claimed |
| CN-109293686-A | One kind containing CuⅡSecondary complex and preparation method thereof and application as urease inhibitor | 辽宁大学 | 2019-02-01 | — | — | CN | claimed |
| US-20210238139-A1 | MODULATORS OF TRYPTOPHAN CATABOLISM | E-THERAPEUTICS PLC (GB) | 2021-08-05 | — | — | US | disclosed |
| EP-3529289-B1 | PROCESS FOR PREPARING CONJUGATED DIENE (CO)POLYMERS IN THE PRESENCE OF A CATALYTIC SYSTEM COMPRISING A PYRIDYL IRON (III) COMPLEX | VERSALIS SPA (IT) | 2020-12-02 | — | — | EP | disclosed |
| US-10793653-B2 | Process for preparing conjugated diene (co)polymers in the presence of a catalytic system comprising a pyridyl iron (III) complex | VERSALIS S.P.A. (IT) | 2020-10-06 | — | — | US | disclosed |
| CN-109293686-B | Containing CuⅡSecondary coordination compound, preparation method thereof and application thereof as urease inhibitor | 辽宁大学 | 2020-08-25 | — | — | CN | disclosed |
| US-20190270832-A1 | PROCESS FOR PREPARING CONJUGATED DIENE (CO)POLYMERS IN THE PRESENCE OF A CATALYTIC SYSTEM COMPRISING A PYRIDYL IRON (III) COMPLEX | VERSALIS S.P.A. (IT) | 2019-09-05 | — | — | US | disclosed |
| CN-109293686-A | One kind containing CuⅡSecondary complex and preparation method thereof and application as urease inhibitor | 辽宁大学 | 2019-02-01 | — | — | CN | disclosed |
| WO-2018073795-A1 | PROCESS FOR PREPARING CONJUGATED DIENE (CO)POLYMERS IN THE PRESENCE OF A CATALYTIC SYSTEM COMPRISING A PYRIDYL IRON (III) COMPLEX | VERSALIS S.P.A. (IT) | 2018-04-26 | — | — | WO | disclosed |
| CN-104927742-B | Polyurethane wood structure glue and preparation method thereof | 上海东和胶粘剂有限公司 | 2017-05-17 | — | — | CN | disclosed |
| CN-104927742-A | Polyurethane wood structure glue and preparation method thereof | SHANGHAI DONGHE ADHESIVE CO LTD | 2015-09-23 | — | — | CN | disclosed |
| EP-1746112-A1 | Polymerisation catalyst system based on monooxime ligands | TOTAL PETROCHEMICALS RESEARCH FELUY (BE) | 2007-01-24 | — | — | EP | disclosed |
| US-7030120-B2 | Nitrogen-containing heterocyclic compounds and benzamide compounds and drugs containing the same | MEIJI SEIKA KAISHA, LTD. (JP) | 2006-04-18 | — | — | US | disclosed |
| US-20040224959-A1 | Nitrogen-containing heterocyclic compounds and benzamide compounds and drugs containing the same | OHKURA NAOTO (JP) | 2004-11-11 | — | — | US | disclosed |
| US-6777414-B1 | INHIBITORS OF TRIGLYCERIDE BIOSYNTHESIS AND SECRETION OF APOLIPOPROTEIN B-CONTAINING LIPOPROTEINS; ARTERIOSCLEROTIC DISEASES; HYPERLIPIDEMIA | MEIJI SEIKA KAISHA, LTD. (JP) | 2004-08-17 | — | — | US | disclosed |
| EP-1180514-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND BENAMIDE COMPOUNDS AND DRUGS CONTAINING THE SAME | MEIJI SEIKA KAISHA LTD. (JP) | 2002-02-20 | — | — | EP | disclosed |
| US-4112100-A | INCREASING THE ENDOGENOUS PRODUCTION OF PROSTAGLANDINS | THE UPJOHN COMPANY (US) | 1978-09-05 | — | — | US | disclosed |
| US-4097481-A | ANTIARRHYTHMIC AGENTS | RIKER LABORATORIES, INC. (US) | 1978-06-27 | — | — | US | disclosed |
| US-4069224-A | N-(PYRIDYLALKYL)BENZAMIDES, IMPROVE PRODUCTION OF PROSTAGLANDINS IN MAMMALS | THE UPJOHN COMPANY (US) | 1978-01-17 | — | — | US | disclosed |
| US-4008326-A | INCREASING PRODUCTION OF PROSTAGLANDINS | THE UPJOHN COMPANY (US) | 1977-02-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210238139-A1 | MODULATORS OF TRYPTOPHAN CATABOLISM | TPH1, KYNU, TPH2 | HPGD 1286/4885RECQL 938/4885MAOA 25/4885 |
| US-20190270832-A1 | PROCESS FOR PREPARING CONJUGATED DIENE (CO)POLYMERS IN THE PRESENCE OF A CATALYTIC SYSTEM COMPRISING A PYRIDYL IRON (III) COMPLEX | AOC3, C5, AOC2 | HPGD 4250/4885RECQL 363/4885MAOA 33/4885 |
| US-20040224959-A1 | Nitrogen-containing heterocyclic compounds and benzamide compounds and drugs containing the same | APOB, NCEH1, LIPC | HPGD 775/4885RECQL 1270/4885MAOA 132/4885 |
| US-10793653-B2 | Process for preparing conjugated diene (co)polymers in the presence of a catalytic system comprising a pyridyl iron (III) complex | AOC3, C5, AOC2 | HPGD 4250/4885RECQL 363/4885MAOA 33/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.